Cytokines and bacterial infections

Biotherapy

Volumn 8, Issue 3-4, 1996, Pages 219-228

  Degré, Miklos ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Bacterial infections; Cytokines; Interferons; Interleukins; Meningococcal disease; Salmonella; Septic shock; Tumor necrosis factor

Indexed keywords

CYTOKINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; BACTERIAL INFECTION; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; MEDIATOR; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; SEPTIC SHOCK;

ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; HUMANS;

EID: 0029971998     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01877208     Document Type: Review

References (77)

1. Barnewall RE, Rikihisa Y. Abrogation of gamma interferoninduced inhibition of Ehrlichia chaffeensis infection in human monnocytes with iron transfemn. Infect Immun 1994; 62: 4804-10.
2. Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophane depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 1994; 62: 3705-11.
3. Benabdelmoumene S, Dumont S, Petit C, Poindron D, Wachsmann D, Klein JP. Activation of human monocytes by Streptocossus mutans serotype f polysaccharide: immunoglobu-lin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect Immun 1991; 59: 3261-6.
4. Bermudez LE. Potential role of cytokines in disseminated mycobacterial infections. Eur J Clin Microbiol Infect Dis 1994; Suppl 2: 29-33.
5. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3872-977.
6. Black CM, Catterall JR, Remington JS. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-7. J Immunol 1987; 138: 491-5.
7. Blanchard KD, Djeu JY, Klein TW, Friedman H, Stewart WE II. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections in mice via activation of PMN function. J Leukocyte Biol 1988; 43:429-35.
8. Bukholm G, Degré M. Effect of human leukocyte Interferon on invasiveness of Salmonella typhimurium in HEp-2 cells cultures. Infect Immun 1983; 42: 1198-202.
9. Bukholm G, Berdal BP, Haug C, Degré M. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect Immun 1984; 45: 62-6.
10. Bukholm G, Degré M. Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures. J Interferon Res 1985; 5:45-53.
11. Byrne GI, Beatty WL, Schobert CS. Cytokine-mediated antimicrobial events:mechanisms of action. In: Sonnenfeld G, Czamiecki C, Nacy C, Byrne GI, Degré M, eds. Cytokines and resistance to nonviral pathogenic infections. Augusta: Biomedical Press, 1992: 169-76.
12. Champsi JH, Bermudez LE, Young LS. The role of cytokines in mycobacterial infection. Biotherapy 1994; 7:187-93.
13. De Boer JP, WolbingGJ, Thijs LG, Baars JW, Wagstaff J, Hack OB. Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharm 1992; 24:135-48.
14. Degré M, Dabi H. Production of an interferon-like agent following inoculation with bacterial vaccine. Proc Soc Exp Biol Med 1971; 137: 233-6.
15. Degré M, Bukholm G, Czamiecki CW. In vitro treatment of HEp-2 cells with human tumor necrosis factor and human interferons reduces invasiveness of Salmonella typhimurium. J Biol Regul Homeost Agents 1989; 3:1-7.
16. Degré M, Bukholm G. Effect of tumor necrosis factor-α on infection with Salmonella typhimurium in a mouse model. J Biol Regul Homeost Agents 1990; 4:157-61.
17. Denis M. Human monocytes/macrophages: NO or NO? J Leukoc Biol 1994; 55:682-4.
18. Djeu JY, Serbousek D, Blanchard DK. Release of tumornecrosis factor by polymorphonuclear leukocytes. Blood 1990; 76: 1405-90.
19. Flick DA, Gifford GE. Pharmacokinetics of murine tumor necrosis factor. J Immunopharmacol 1986; 8: 89-97.
20. Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, Cerami C. Antibodies to cachectin/tumor necrosis factor reduce interleukin Ib and interleukin 6 appearance during lethal bacteremia. J Exp Med 1989; 170: 1627-33.
21. Gebran SJ, Yamamoto Y, Newton C, Klein TW, Friedman H. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxyge species, bitric oxide, tryptophan, and iron (III). Infect Immun 1994; 62: 3197-205.
22. Girardin E, Grau GE, Dayer J-M, Roux-Lombard P. The J5 Study Group, Lambert P-H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319: 397-400.
23. Green SJ, Nacy CA. L-arginine-derived nitric oxide is an antimicrobial effector molecule. ASM News 1994; 60: 83-6.
24. Grossberg SE, Burleson G, Morahan P, Jameson P. A bacterial protein inducing antiviral resistance and high titres of Interferon. Progr Immunobiol Standard 1972; 5: 274-8.
25. Hack CE, De Groot HER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJMS, Eerenberg-Belmer AJM, Thijs LG, Aarden LA. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-10.
26. Hack CE, Hart M, Van Schijndel RJMS, Eerenberg AJM, Nuijens JH, Thijs LG, Aarden LA. Infect Immunol 1992; 60: 2835-42.
27. Havell EA. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 1989; 143: 2894-9.
28. Hershman MJ, Polk HC Jr, Pietsch JD, Kuftinec D, Sonnenfeld G. Modulation of Klebsiella pneumonia infection of mice by interferon-gamma. Clin Exp Immunol 1988; 87:406-9.
29. Hershman MJ, Polk HC Jr, Pietsch JD, Shields RE, Wellhausen SR, Sonnenfeld G. Modulation of infection by gamma interferon treatment following trauma. Infect Immun 1988; 56: 2412-6.
30. Hershman MJ, Sonnenfeld G, Mays BW, Fleming F, Trachtenberg LS, Polk HC Jr. Effects of interferon-γ treatment on surgically simulated wound infection in mice. Microbiol Pathogenesis 1988; 4:165-8.
31. Hershman MJ, Pietsch JD, Trachtenberg L, Mooney THR, Shields RE, Sonnenfeld G. Protective effect of recombinant human tumor necrosis factor-a against surgically simulated wound infection in mice. Brit J Surg 1989; 76: 1282-6.
32. Høgåsen ARM, Abrahamsen TG. Increased C3 production in human monocytes after stimulation with Candida albicans is suppressed by granulocyte-macrophages colony-stimulating factor. Infect Immun 1993; 61:1779-85.
33. Høgåsen AKM, Hestdal K, Abrahamsen TG. Granulocyte-macrophage colony-stimulating factor suppresses basal and lypopolysaccharide-stimulated complement factor production in human monocytes. J Immunol 1993; 151: 3215-24.
34. Hopken U, Oppermann M, Montz H, Mohr M, Burchardi H, Gotze O. Treatment of septic shock in pigs with a monoclonal antibody with specificity for a c5a-neoepitope. Immunobiology 1992; 184:430 (Abstract).
35. Izadkah Z, Mandel AD, Sonnenfeld G. Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2. J Interferon Res 1980; 1: 137-45.
36. Kagaya K, Watanabe K, Fukazawa Y. Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect Immun 1989; 57: 609-15.
37. Kiderlen AF, Kaufmann SHE, Lohmann-Mathes ML. Protection of mice against intracellular bacterium L. monocytogenes by recombinant immune interferon. Eur J Immunol 1984; 14: 964-7.
38. Kühn M, Goebel W. Induction of cytokines in phagocytic mammalian cells infected with virulent and avirulent Listeria strains. Infect Immun 1994; 62: 348-56.
39. Langermars JAM, Van Furth R. Cytokines and the host defense against Listeria monocytogenes and Salmonella typhimurium. Biotherapy 1994; 7: 169-79.
40. Livingston DH, Malanoni MA, Sonnenfeld G. Immune enhancement by tumor necrosis factor-alpha improves antibi-otic efficacy after hemorrhagic shock. J Trauma 1989; 29: 967-71.
41. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992; 13:169-72.
42. Luoie A, Baltch AL, Smith RP, Franke MA, Ritz WJ, Singh JK, Gordon MA. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect Immun 1994; 62: 2761-72.
43. Malangoni MA, Livingston DH, Sonnenfeld G, Polk HC Jr. Interferon gamma and tumor necrosis factor alpha. Use in Gram-negative infection after shock. Arch Surg 1990; 125: 444-6.
44. Mancuso G, Tomasello F, Migliardo M, Delfino D, Cochran J, Cook JA, Teti G. Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect Immun 1994; 62:4997-5002.
45. Mastroeni P, Arena A, Costa GB, Liberto MC, Bonina L, Hormaeche CE. Serum TNFa in mouse typhoid and enhancement of a salmonella infection by anti-TNFα antibodies. Microbial Pathogenesis 1991; 11: 33-8.
46. Mathison JC, Wolfson E, Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81: 1925-37.
47. Matsumura H, Onozuka K, Terada Y, Nakano Y, Nakano M. Effect of murine recombinant interferon-γ in the protection of mice against Salmonella, hit J Immunopharmac 1990; 12: 49-56.
48. Muotiala A, Mäkelä PH. The role of IFN-γ in murine Salmonella typhimurium infection. Microb Pathogenesis 1990; 8: 135-41.
49. Muotiala A, Mäkelä PH. Role of gamma Interferon in late stages of murine salmonellosis. Infect Immun 1993; 61:4248-53.
50. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J Immunol 1990; 144: 1935-41.
51. Nakano Y, Kasahara T, Mukaida N, Ko Y-C, Nakano M, Matsushima K. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun 1994; 62: 377-83.
52. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 319-26.
53. Nauciel C, Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 1992; 60:450-4.
54. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550-2.
55. Paguirigan AM, Byrne GI, Becht S, Carlin JM. Cytokinemediated indoleamin 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect Immun 1994; 62: 1131-6.
56. Parsonnet J, Gillis ZA. Production of tumor necrosis factor by human monocytes in response to toxic-shock-syndrome toxin1. J Infect Dis 1988; 158: 1026-33.
57. Pierangeli SS, Sonnenfeld G. Treatment of murine macrophages with murine interferon-γ and tunor necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa. Clin Exp Immunol 1993; 93: 165-71.
58. Polk HC Jr, Cheadle WG, Livingston DH, Rodriguez DH, Starke KM, Izu AE, Jaffe HS, Sonnenfeld G. A random prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Amer J Surg 1992; 163: 191-196.
59. Ramarathinam L, Shaban RA, Niesei DW, Kumpel GR. Interferon gamma (IFN-7) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium chalenge. Microbial Pathogenesis 1991; 11: 347-56.
60. Rank RG, Ramsey KH, Pack EA, Waiiams DM. Effect of gamma interferon on resolution of murine Chlamydial infection. Infect Immun 1992; 60: 4427-9.
61. Remick DG. Cytokines and septic shock. In: Griffin GE, ed. Cytokines in infection. London: Balliere Tindall, 1994: 37-50.
62. Starnes HF, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS. Anti IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-a-challenge in mice. J Immunol 1990; 145: 4185-91.
63. Stevens MG, Pugh GW Jr, Tabatabai LB. Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infect Immun 1992; 60:4407-9.
64. Summersgill JT, Powell LA, Buster BL, Miller RD, Ramirez JA. Killing of Legionella pneumophila by nitric oxide in gamma-interferon-activated macrophages. J Leukoc Biol 1992; 52: 625-9.
65. Timmerman CP, Mattsson E, Martinez-Martinez L, De Graaf L, Van Strijp JAG, Verbrugh HA, Fleehr A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglucans. Infect Immun 1993; 61: 4167-72.
66. Vacheron F, Guenounou M, Nauciel C. Adjuvant active peptidoglucans induce secretion of a cytotoxic factor by macrophages. In: Seidl PH, Schleifer KH, eds. Biological properties of peptidoglucan. New Yoik: W. de Gruyter & Co., 1986: 395.
67. Van Dissel JT, Stikkelbroeck JJM, Michel BC, Van den Barselaar MTh, Leijh PVC, Van Furth R. Inability of recombinant interferon-7 to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol 1987; 139: 1673-8.
68. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin Immunol Immunopathol 1987; 45: 348-55.
69. Waage A, Espevik T. Interleukin 1 potentiates the lethal effect of tumor necrosis factor/cachectin in mice. J Exp Med 1988; 167: 1987-92.
70. Waage A, Brandtzg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with men ingococcal septic shock. J Exp Med 1989; 169: 333-8.
71. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor-α, interleukin-1, and interleukin-6 in meningococcal meningitis. Relation to inflammatory response. J Exp Med 1989; 170: 1859-67.
72. Waage A, Brandtzaeg P, Espevik T, Halstensen A. Current understanding of the pathogenesis of Gram-negative shock. Infect Dis Clin North Amer 1991; 5: 781-91.
73. Waage A. Presence and involvement of TNF in septic shock. In: Beutler B, ed. Tumor necrosis factors: The molecules and their emerging role in medicine. New York: Raven Press, 1992: 275-83.
74. Waage A, Redl H, Schlag G, Schade U. The cytokine network in sepsis II: IL-1 and IL-6. In: Schlag G, Redl H, eds. Pathophysiology of shock, sepsis and organ failure. Berlin: Springer Verlag, 1993:491-501.
75. Waage A, Halstensen A, Espevik T, Brandtzseg P. Cytokines in meningococcal disease. In: Griffin GE, ed. Cytokines in infection. London: Balliere Tindall, 1994: 97-108.
76. Xiong H, Kawamura I, Nishibori T, Mitshuyama M. Cytokine gene expression in mice at an early stage of infection with various strains of Listeria spp. differing in virulence. Infect Immun 1994; 62: 3649-54.
77. Yamamoto Y, Okubo S, Klein TW, Onozaki K, Saito T, Friedman H. Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA. Infect Immun 1994; 62: 3947-56.